Greenleaf Trust’s Aemetis AMTX Stock Holding History

Greenleaf Trust’s Portfolio AMTX Stock Details AMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-11,000	Closed	-$67K	–	746
2022 Q3	$67K	Hold	11,000	–	–	﹤0.01%	696
2022 Q2	$54K	Hold	11,000	–	–	﹤0.01%	705
2022 Q1	$139K	Buy	+11,000	New	+$121K	﹤0.01%	740

Other funds holding AMTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

ECA

Encompass Capital Advisors New York $3.34B AUM 167.64% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Greenleaf Trust's AMTX Position: Q4 2022 in Review

Greenleaf Trust sold out of Aemetis (AMTX) in Q4 2022, closing a stake of 11,000 shares — an estimated $67K sold.

Greenleaf Trust first reported a position in AMTX in Q1 2022 and held it in 3 quarters. The position peaked at $139K in Q1 2022. 91 funds tracked by Wall St. Rank hold AMTX as of Q4 2022.

Greenleaf Trust reported no remaining Aemetis position as of Q4 2022 after selling out during the quarter.
Greenleaf Trust sold 11,000 Aemetis shares in Q4 2022, an estimated $67K.
Greenleaf Trust first reported a position in Aemetis in Q1 2022 and held it in 3 quarters.
Greenleaf Trust's Aemetis position peaked at $139K in Q1 2022.
91 funds tracked by Wall St. Rank held Aemetis as of Q4 2022.

Based on Greenleaf Trust's 13F filing for Q4 2022, filed 25 Jan 2023.